Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services category PRINCETON, NJ – 2021 年 10 月 25 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today…
在 2020 年，有近 1000 万人死于癌症，尽管取得了巨大进步，但癌症仍然是全世界的首要死因[1]。Antibody Drug Conjugates (ADCs) when first approved in 2000, seemed…
Both the FDA and EMA have made statements that support the concept of using real world evidence (RWE) for regulatory decision-making. Historical control arms represent a way to take a…
Strategic consulting within drug discovery and development is an exciting career choice for many. Unlike a biotechnology or pharmaceutical enterprise, where the assets one typically works on are within that…
利用 Pinnacle 21 临床数据管理和自动化套件提高临床试验申报数据的速度和质量。
As Life-Science manufacturers embrace new technologies to speed time to market and products become more complex, the FDA has created an Office of Digital Transformation (ODT) to support the effective…
运用先进 SAS 编程技术优化病毒学数据集整理流程。
Alzheimer’s disease (AD) is one of the most common forms of neurodegenerative dementia in the United States. In fact, the Alzheimer’s Association predicts that by the year 2050, the number…
© 2025 Certara. 保留所有权力。 | 隐私政策
